Treatment with Arenobufagin can reverse the EMT process of lung cancer cells by inhibiting the cascade activation of the IKKβ/NF-κB pathway, thereby effectively inhibiting the metastasis of lung cancer [94]. This evidence concerns the gene NFKB1 and lung carcinoma.